[HTML][HTML] Treatment options for motor and non-motor symptoms of Parkinson's disease

FC Church - Biomolecules, 2021 - mdpi.com
Parkinson's disease (PD) usually presents in older adults and typically has both motor and
non-motor dysfunctions. PD is a progressive neurodegenerative disorder resulting from …

Mitochondrial dysfunction in the development and progression of neurodegenerative diseases

J Johnson, E Mercado-Ayon, Y Mercado-Ayon… - Archives of biochemistry …, 2021 - Elsevier
In addition to ATP synthesis, mitochondria are highly dynamic organelles that modulate
apoptosis, ferroptosis, and inflammasome activation. Through executing these varied …

Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics

A Akhtar, A Andleeb, TS Waris, M Bazzar… - Journal of Controlled …, 2021 - Elsevier
The central nervous system (CNS) encompasses the brain and spinal cord and is
considered the processing center and the most vital part of human body. The central …

[HTML][HTML] Alpha-synuclein as a biomarker of Parkinson's disease: good, but not good enough

U Ganguly, S Singh, S Pal, S Prasad… - Frontiers in aging …, 2021 - frontiersin.org
Parkinson's disease (PD) is the second most common neurodegenerative disorder of the
elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed …

Ferritinophagy‐mediated ferroptosis involved in paraquat‐induced neurotoxicity of dopaminergic neurons: implication for neurotoxicity in PD

Y Zuo, J Xie, X Li, Y Li, A Thirupathi… - Oxidative medicine …, 2021 - Wiley Online Library
Parkinson's disease (PD) is a progressive nervous system disorder. Until now, the molecular
mechanism of its occurrence is not fully understood. Paraquat (PQ) was identified as a …

[HTML][HTML] RETRACTED ARTICLE: Facial expressions can detect Parkinson's disease: preliminary evidence from videos collected online

MR Ali, T Myers, E Wagner, H Ratnu, E Dorsey… - NPJ digital …, 2021 - nature.com
A prevalent symptom of Parkinson's disease (PD) is hypomimia—reduced facial
expressions. In this paper, we present a method for diagnosing PD that utilizes the study of …

[HTML][HTML] Role of SNAREs in neurodegenerative diseases

A Margiotta - Cells, 2021 - mdpi.com
Neurodegenerative diseases are pathologies of the central and peripheral nervous systems
characterized by loss of brain functions and problems in movement which occur due to the …

[HTML][HTML] Sex differences in the blood–brain barrier and neurodegenerative diseases

CM Weber, AM Clyne - APL bioengineering, 2021 - pubs.aip.org
The number of people diagnosed with neurodegenerative diseases is on the rise. Many of
these diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and …

[HTML][HTML] New avenues for Parkinson's disease therapeutics: disease-modifying strategies based on the gut microbiota

M Lorente-Picón, A Laguna - Biomolecules, 2021 - mdpi.com
Parkinson's disease (PD) is a multifactorial neurodegenerative disorder that currently affects
1% of the population over the age of 60 years, and for which no disease-modifying …

[HTML][HTML] Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson's Disease

DA Madsen, SI Schmidt, M Blaabjerg, M Meyer - Cells, 2021 - mdpi.com
Parkin and α-synuclein are two key proteins involved in the pathophysiology of Parkinson's
disease (PD). Neurotoxic alterations of α-synuclein that lead to the formation of toxic …